Faculty, Staff and Student Publications
Language
English
Publication Date
4-1-2021
Journal
JACC: Basic to Translational Science
DOI
10.1016/j.jacbts.2021.01.002
PMID
33681537
PMCID
PMC7909907
PubMedCentral® Posted Date
February 2021
PubMedCentral® Full Text Version
Post-print
Abstract
There is ongoing debate as to whether cardiac complications of coronavirus disease-2019 (COVID-19) result from myocardial viral infection or are secondary to systemic inflammation and/or thrombosis. We provide evidence that cardiomyocytes are infected in patients with COVID-19 myocarditis and are susceptible to severe acute respiratory syndrome coronavirus 2. We establish an engineered heart tissue model of COVID-19 myocardial pathology, define mechanisms of viral pathogenesis, and demonstrate that cardiomyocyte severe acute respiratory syndrome coronavirus 2 infection results in contractile deficits, cytokine production, sarcomere disassembly, and cell death. These findings implicate direct infection of cardiomyocytes in the pathogenesis of COVID-19 myocardial pathology and provides a model system to study this emerging disease.
Keywords
cardiomyocyte, coronavirus disease 2019, engineered heart tissue, myocarditis, severe acute respiratory syndrome coronavirus 2
Published Open-Access
yes
Recommended Citation
Bailey, Adam L; Dmytrenko, Oleksandr; Greenberg, Lina; et al., "Sars-Cov-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis" (2021). Faculty, Staff and Student Publications. 1950.
https://digitalcommons.library.tmc.edu/uthmed_docs/1950